Annual Debt To Equity
133.49
+124.37+1363.71%
31 December 2023
Summary:
Amneal Pharmaceuticals annual debt to equity ratio is currently 133.49, with the most recent change of +124.37 (+1363.71%) on 31 December 2023. During the last 3 years, it has risen by +124.20 (+1336.92%). AMRX annual debt to equity is now at all-time high.AMRX Debt To Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Debt To Equity
-27.12
+18.35+40.36%
30 September 2024
Summary:
Amneal Pharmaceuticals quarterly debt to equity ratio is currently -27.12, with the most recent change of +18.35 (+40.36%) on 30 September 2024. Over the past year, it has dropped by -35.25 (-433.58%). AMRX quarterly debt to equity is now -120.32% below its all-time high of 133.49, reached on 31 December 2023.AMRX Quarterly Debt To Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AMRX Debt To Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +1363.7% | -433.6% |
| 3 y3 years | +1336.9% | -445.0% |
| 5 y5 years | +2442.7% | -324.3% |
AMRX Debt To Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +1649.5% | -120.3% | +40.4% |
| 5 y | 5 years | at high | +2442.7% | -120.3% | +40.4% |
| alltime | all time | at high | +3669.3% | -120.3% | +40.4% |
Amneal Pharmaceuticals Debt To Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -27.12(-40.4%) |
| June 2024 | - | -45.47(+10.1%) |
| Mar 2024 | - | -41.31(-130.9%) |
| Dec 2023 | 133.49(+1363.7%) | 133.49(+1541.9%) |
| Sept 2023 | - | 8.13(-5.6%) |
| June 2023 | - | 8.61(-7.2%) |
| Mar 2023 | - | 9.28(+1.8%) |
| Dec 2022 | 9.12(+19.5%) | 9.12(-0.9%) |
| Sept 2022 | - | 9.20(-7.1%) |
| June 2022 | - | 9.90(+41.2%) |
| Mar 2022 | - | 7.01(-8.1%) |
| Dec 2021 | 7.63 | 7.63(-2.9%) |
| Sept 2021 | - | 7.86(-2.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2021 | - | 8.05(-6.9%) |
| Mar 2021 | - | 8.65(-6.9%) |
| Dec 2020 | 9.29(-18.1%) | 9.29(-1.0%) |
| Sept 2020 | - | 9.38(+1.4%) |
| June 2020 | - | 9.25(-6.2%) |
| Mar 2020 | - | 9.86(-13.1%) |
| Dec 2019 | 11.34(+116.0%) | 11.34(-6.2%) |
| Sept 2019 | - | 12.09(+110.3%) |
| June 2019 | - | 5.75(+2.7%) |
| Mar 2019 | - | 5.60(+6.7%) |
| Dec 2018 | 5.25(-240.4%) | 5.25(-8.5%) |
| Sept 2018 | - | 5.74(+3.6%) |
| June 2018 | - | 5.54(-248.1%) |
| Dec 2017 | -3.74 | -3.74 |
FAQ
- What is Amneal Pharmaceuticals annual debt to equity ratio?
- What is the all time high annual debt to equity for Amneal Pharmaceuticals?
- What is Amneal Pharmaceuticals annual debt to equity year-on-year change?
- What is Amneal Pharmaceuticals quarterly debt to equity ratio?
- What is the all time high quarterly debt to equity for Amneal Pharmaceuticals?
- What is Amneal Pharmaceuticals quarterly debt to equity year-on-year change?
What is Amneal Pharmaceuticals annual debt to equity ratio?
The current annual debt to equity of AMRX is 133.49
What is the all time high annual debt to equity for Amneal Pharmaceuticals?
Amneal Pharmaceuticals all-time high annual debt to equity ratio is 133.49
What is Amneal Pharmaceuticals annual debt to equity year-on-year change?
Over the past year, AMRX annual debt to equity ratio has changed by +124.37 (+1363.71%)
What is Amneal Pharmaceuticals quarterly debt to equity ratio?
The current quarterly debt to equity of AMRX is -27.12
What is the all time high quarterly debt to equity for Amneal Pharmaceuticals?
Amneal Pharmaceuticals all-time high quarterly debt to equity ratio is 133.49
What is Amneal Pharmaceuticals quarterly debt to equity year-on-year change?
Over the past year, AMRX quarterly debt to equity ratio has changed by -35.25 (-433.58%)